Herbs (Global Traditional) · Japanese Kampo
Ninjin (Panax ginseng) (Panax ginseng)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Panax ginseng contains ginsenosides, bioactive compounds that modulate glucose metabolism and support cardiovascular function through multiple cellular pathways. Clinical studies demonstrate significant improvements in blood sugar regulation and metabolic parameters.
Ninjin (Panax ginseng) is a perennial plant native to East Asia, particularly Korea, China, and mountainous regions, with roots harvested after 4-6 years of cultivation. The root undergoes steaming (for red ginseng) or drying (for white ginseng) to yield extracts rich in ginsenosides, which are triterpenoid saponins.
A systematic review of 119 published clinical trials found 79.8% reported positive effects, primarily in cardiovascular and metabolic conditions, typically using treatments for under 3 months. A 12-week RCT (PMID: 29348727) demonstrated significant reductions in fasting glucose (7.2%), postprandial glucose (10.7%), and glucose AUC (7.7%) in participants with elevated baseline glucose. Safety was confirmed in a review of 44 RCTs showing adverse event rates similar to placebo.
Korean red ginseng extract powder: 1 g/week for long-term use (3 years studied). Root extract: 1-2 g/day for 4 weeks in healthy volunteers. Berry extracts: studied in 12-week trials for glycemic control (exact mg not specified). Most clinical trials used 8-12 week durations. Consult a healthcare provider before starting any new supplement.
Ginsenosides, the primary bioactive compounds in Panax ginseng, enhance insulin sensitivity by activating AMPK pathways and modulating glucose transporters. These compounds also support cardiovascular function through nitric oxide synthesis enhancement and inhibition of inflammatory cytokines like TNF-α and IL-6. Additionally, ginsenosides interact with glucocorticoid receptors to help regulate stress response and metabolic homeostasis.
A 12-week randomized controlled trial demonstrated that Panax ginseng supplementation reduced fasting glucose by 7.2% and postprandial glucose by 10.7% in pre-diabetic participants. A comprehensive systematic review analyzing 119 clinical trials found that 79.8% reported positive effects on various health parameters. The evidence quality is considered moderate, with most studies showing consistent benefits for glucose metabolism and cardiovascular markers. However, study durations and dosages vary significantly across trials, requiring standardization for optimal therapeutic protocols.
Panax ginseng is generally well-tolerated but can cause insomnia, headaches, and gastrointestinal upset in some individuals. It may interact with anticoagulant medications like warfarin, potentially increasing bleeding risk due to its effects on platelet aggregation. Ginseng can also interact with diabetes medications by enhancing their glucose-lowering effects, requiring careful monitoring. Pregnant and breastfeeding women should avoid use due to insufficient safety data, and individuals with hormone-sensitive conditions should consult healthcare providers before supplementation.
